Reducing ethnic inequities: Patterns of asthma medication use and hospital discharges in Māori in Aotearoa New Zealand
Respirology · 2025
DOI: 10.1111/resp.14865 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respirology, 2025. Verfasst von Allie Eathorne und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Institute of New Zealand, Wellington, New Zealand. Hauptthemen laut MEDLINE: Anti-Asthmatic Agents, Asthma, Hospitalization, Patient Discharge. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Health Research Council of New Zealand.
Abstract (Originalsprache)
Background and Objective In Aotearoa New Zealand (NZ) widespread transition to budesonide/formoterol maintenance and/or reliever regimens in clinical practice is temporally associated with reduced rates of asthma hospitalization. It is unknown whether this association is observed in Māori, the indigenous population of NZ, who experience a disproportionate burden from asthma. We investigated patterns in asthma medication use and hospital admissions in Māori in NZ.
Methods
Review of NZ national dispensing data for asthma inhaler medications and asthma hospital discharge data from January 2013 to December 2023 in the 12+ age group, with calculation of the relative change in dispensed medication and asthma hospitalization rates for Māori and non‐Māori. The most recent six‐month period, July to December 2023, is compared with the corresponding six‐month period 4 years earlier, July to December 2019.
Results
Budesonide/formoterol dispensing increased for both Māori and non‐Māori for 2019–2023, with a relative 111% and 115% increase, respectively. Between the two periods, asthma hospital discharges reduced from 142.5 to 97.3 per 100,000, absolute difference 45.2 per 100,000, a 32% reduction for Māori; and 49.4–37.9 per 100,000, absolute difference 11.5 per 100,000; a 23% reduction for non‐Māori.
Conclusion
The temporal association between a marked increase in dispensing of budesonide/formoterol maintenance and/or reliever regimens and reduced asthma hospitalization was observed for Māori and non‐Māori, with a greater reduction in asthma hospitalization for Māori. Despite this reduction in health inequities, asthma hospitalization rates are two and a half times greater for Māori compared to non‐Māori. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Research Institute of New Zealand, Wellington, New Zealand.
- School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand.
- Faculty of Medicine and Health Sciences, Auckland University, Auckland, New Zealand.
- Department of Medicine, University of Otago Wellington, Wellington, New Zealand.
ORCID-Profile: Allie Eathorne, Jonathan Noble, Lee Hatter, Tom Hills, Matire Harwood, Mark Weatherall, Richard Beasley
Förderung
- Health Research Council of New Zealand
Zitieren
APA
Eathorne, A., Noble, J., Hatter, L., Hills, T., Te Paa, S., Harwood, M., Weatherall, M., & Beasley, R. (2025). Reducing ethnic inequities: Patterns of asthma medication use and hospital discharges in Māori in Aotearoa New Zealand. Respirology. https://doi.org/10.1111/resp.14865
Vancouver
Eathorne A, Noble J, Hatter L, Hills T, Te Paa S, Harwood M, et al. Reducing ethnic inequities: Patterns of asthma medication use and hospital discharges in Māori in Aotearoa New Zealand. Respirology. 2025. doi:10.1111/resp.14865
BibTeX
@article{Eathorne2025,
author = {Eathorne, Allie and Noble, Jonathan and Hatter, Lee and Hills, Tom and Te Paa, Selwyn and Harwood, Matire and Weatherall, Mark and Beasley, Richard},
title = {Reducing ethnic inequities: Patterns of asthma medication use and hospital discharges in Māori in Aotearoa New Zealand},
journal = {Respirology},
year = {2025},
doi = {10.1111/resp.14865}
}
EUVIMED